An International Validation of the “DECAF Score” to Predict Disease Severity and Hospital Mortality in Acute Exacerbation of COPD in the UAE
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The DECAF score (the Dyspnea, Eosinopenia, Consolidation, Academia, and Atrial fibrillation score) has been adopted in some hospitals to predict the severity of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). However, DECAF score has not been widely evaluated or used in Middle Eastern countries. The present study aimed to validate the DECAF score for predicting in-hospital mortality in patients with AECOPD in the United Arab Emirates (UAE). This was a retrospective, observational study conducted in 19 hospitals in the UAE. Data were retrieved from the electronic records of patients admitted for AECOPD in 17 hospitals across the country. Patients aged more than 35 years who were diagnosed with AECOPD were included in the study. The validation of the DECAF Score for inpatient death, 30-days death, and 90-day readmission was conducted using the Area Under the Receiver Operator curve (AUROC). The AUROCDECAF curves for inpatient death, 30-days death, and 90-day readmission were 0.8 (95% CI: 0.8-0.9), 0.8 (95% CI: 0.7-0.8), and 0.8 (95% CI: 0.8-0.8), respectively. The model was a satisfactory fit to the data (Hosmer–Lemeshow statistic = 0.195, Nagelkerke R 2 = 31.7%). There were significant differences in means of length of stay across patients with different DECAF score ( P = .008). Patients with a DECAF score of 6 had the highest mean length of stay, which was 29.8 ± 31.4 days. Patients with a DECAF score of 0 had the lowest mean length of stay, which was 3.6 ± 2.0 days. The DECAF score is a strong predictive tool for inpatient death, 30 days mortality and 90-day readmission in UAE hospital settings. The DECAF score is an effective tool for predicating mortality and other disease outcomes in patients with AECOPD in the UAE; hence, clinicians would be more empowered to make appropriate clinical decisions by using the DECAF score.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Almarshoodi et al. [16] validated the DECAF score within GCC populations and demonstrated its usefulness in predicting the disease severity and hospital mortality among patients hospitalized with AECOPD.”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the 90-day readmission rate estimated for the UAE (35.9%) falls in the upper range of the published readmission rates [16,23].”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, in that study mortality among hospitalized exacerbation patients was 24.4%, with a 90-day readmission rate of 35.9% [16].”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“with a 90-day readmission rate of 35.9% [16].”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [16]
The cited source says what the claim attributes to it.
In the citing paper
“as prognostic scoring systems may assist clinicians in identifying high-risk patients and optimizing resource allocation during acute exacerbations [16].”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pathogenesis of Chronic Obstructive Pulmonary Disease
MacNee, W. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-045sr · Cited by 448
Steer, J., Gibson, J., & Bourke, S. C. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202103 · Cited by 388
Epidemiology of Chronic Obstructive Pulmonary Disease
Ruvuna, L., & Sood, A. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.05.002 · Cited by 201
Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD
Echevarria, C., Steer, J., Heslop-Marshall, K., Stenton, S., Hickey, P. M., Hughes, R. J., Wijesinghe, M., Harrison, R., Steen, N. D., Simpson, A. J., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207775 · Cited by 149
Self-citationEchevarria, C., Gray, J., Hartley, T., Steer, J., Miller, J. M., Simpson, A. J., Gibson, G. J., & Bourke, S. C. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-211197 · Cited by 89
Self-citationHuang, Q., He, C., Xiong, H., Shuai, T., Zhang, C., Zhang, M., Wang, Y., Zhu, L., Lü, J., & Liu, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037923 · Cited by 49
The patterns and determinants of telemedicine use during the COVID-19 crisis: A nationwide study
Meslamani, A. Z. A., Aldulaymi, R., Sharu, H. E., Alwarawrah, Z., Ibrahim, O. M., & Mazrouei, N. A. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.05.020 · Cited by 49
Chen, L., Chen, L., Zheng, H., Wu, S., & Wang, S. (2021) · Chronic Respiratory Disease · doi:10.1177/14799731211060051 · Cited by 45
An emergency plan for management of COVID-19 patients in rural areas
Al Meslamani, A. Z., Kassem, A. B., El‐Bassiouny, N. A., & Ibrahim, O. M. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14563 · Cited by 39
Self-citationMalik, R., & Sangwan, V. (2017) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_148_17 · Cited by 33
Research works printed but not linked: 1
- 10.1136/thoraxjnl-2015-207775 · DOI
Cited by
Elshafei, A., Safi, I., Aljoaid, A., Alanazi, O., & Almahd, S. (2026) · Healthcare · doi:10.3390/healthcare14131962
Metadata
- Authors
- Almarshoodi, K., Echevarria, C., Kassem, A., Mahboub, B., Salameh, L., & Ward, C.
- Affiliations
- Newcastle University (GB)
- Emirates Health Services, Ras AlKhaima, United Arab Emirates
- Rashid Hospital (AE)
- Corresponding author
- Almarshoodi, Khadeijah
- Venue
- Hospital Pharmacy
- Publisher
- SAGE Publications
- Published
- 2023-11-03
- Volume
- 59
- Issue
- 2
- Pages
- 234-240
- ISSN
- 0018-5787 (ISSN-L)
- 1945-1253
- PMC
- PMC10913885
- OpenAlex
- W4388293948
- Semantic Scholar
- 08e6466c0f3184285ce7c8679efa8c3c352146f9
- Cited by
- 8
- References
- 20
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Hospital Pharmacy (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity) (cc-by-nc)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- DECAF score, COPD exacerbations, chronic obstructive pulmonary disease, in-hospital mortality, 30-day mortality, hospital readmission, disease severity prediction, prognostic score validation, United Arab Emirates, length of hospital stay
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An International Validation of the “DECAF Score” to Predict Disease Severity and Hospital Mortality in Acute Exacerbation of COPD in the UAE. https://app.cochat.ai/papers/10.1177/00185787231209218
- The paper
- Almarshoodi, K., Echevarria, C., Kassem, A., Mahboub, B., Salameh, L., & Ward, C. (2024). An International Validation of the “DECAF Score” to Predict Disease Severity and Hospital Mortality in Acute Exacerbation of COPD in the UAE. Hospital Pharmacy. https://doi.org/10.1177/00185787231209218
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.